HEART FAILURE PRESERVED EJECTION FRACTION
Clinical trials for HEART FAILURE PRESERVED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE PRESERVED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE PRESERVED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New device aims to unclog the Heart's drain for stubborn heart failure patients
Disease control ENROLLING_BY_INVITATIONThis study tests a small device, called the Coronary Sinus Reducer, in 35 people with a type of heart failure where the heart pumps well but still has trouble filling with blood. The device is placed in a vein of the heart to help lower pressure during exercise. The goal is to se…
Matched conditions: HEART FAILURE PRESERVED EJECTION FRACTION
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Gout drug allopurinol may boost heart function in african americans with resistant hypertension
Symptom relief OngoingThis study tests whether allopurinol, a common gout medication, can improve heart function in African American veterans with resistant hypertension. Participants take allopurinol for 8 weeks, and researchers measure changes in heart function, exercise ability, and quality of life…
Matched conditions: HEART FAILURE PRESERVED EJECTION FRACTION
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC